Financial results - ALXMEDCONSULT SRL

Financial Summary - Alxmedconsult Srl
Unique identification code: 32685140
Registration number: J26/60/2014
Nace: 8621
Sales - Ron
136.702
Net Profit - Ron
105.004
Employee
3
The most important financial indicators for the company Alxmedconsult Srl - Unique Identification Number 32685140: sales in 2023 was 136.702 euro, registering a net profit of 105.004 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Alxmedconsult Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 28.942 42.715 44.981 48.564 58.578 74.371 81.451 100.195 108.649 136.702
Total Income - EUR 28.945 42.716 44.982 48.565 58.579 74.372 83.519 100.196 108.651 136.900
Total Expenses - EUR 7.220 12.442 13.411 11.751 22.970 51.646 44.952 39.993 43.645 30.733
Gross Profit/Loss - EUR 21.725 30.274 31.570 36.814 35.609 22.726 38.568 60.203 65.006 106.167
Net Profit/Loss - EUR 20.856 28.991 31.134 36.338 35.023 21.983 37.753 59.459 63.947 105.004
Employees 2 2 2 2 3 4 3 3 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 26.2%, from 108.649 euro in the year 2022, to 136.702 euro in 2023. The Net Profit increased by 41.250 euro, from 63.947 euro in 2022, to 105.004 in the last year.

Check the financial reports for the company - Alxmedconsult Srl

Rating financiar

Financial Rating -
Alxmedconsult Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Alxmedconsult Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Alxmedconsult Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Alxmedconsult Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Alxmedconsult Srl - CUI 32685140

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 662 447 224 62 65.777 48.547 31.019 14.326 9.287 9.957
Current Assets 21.756 50.790 32.488 38.617 43.868 5.720 31.307 48.459 56.704 142.717
Inventories 0 229 0 0 20 0 0 36 20 20
Receivables 3.039 1.090 3.578 4.243 4.081 5.285 28.410 44.449 55.831 126.014
Cash 18.717 49.470 28.910 34.374 39.767 435 2.897 3.974 853 16.683
Shareholders Funds 20.901 50.066 31.210 36.381 70.737 22.230 37.855 59.683 64.035 105.365
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 1.517 1.171 1.502 2.297 38.908 32.164 25.781 4.349 1.956 48.534
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 142.717 euro in 2023 which includes Inventories of 20 euro, Receivables of 126.014 euro and cash availability of 16.683 euro.
The company's Equity was valued at 105.365 euro, while total Liabilities amounted to 48.534 euro. Equity increased by 41.524 euro, from 64.035 euro in 2022, to 105.365 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Alxmedconsult Srl

Comments - Alxmedconsult Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.